The nation of Zimbabwe has rejected a substantial American health deal valued at $367m (£272m) over five years over Washington's request for sensitive data.
The decision was revealed after a government memo from December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "unbalanced".
A government spokesperson has since explained that the US was seeking biological samples for scientific study and commercial gain while was unwilling to guarantee the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had donated over $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged more dialogue to reach a agreement acceptable to both sides so the country's critical HIV treatment initiative can continue.
Broader Context
This rejection comes after a similar case in Kenya, where a high court blocked a similar health funding agreement following legal challenges were raised about the security of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had administered aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance transparency and responsibility.
According to statements, Sixteen African countries have so far agreed to these new agreements, constituting more than $18.3bn of fresh investment.
Details of the Rejected Deal
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment through American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"Our nation was requested to provide its genetic material and health information over an extended period, with no corresponding guarantee of benefiting from any medical innovations – like new medicines or tests – that could be developed from that shared data," his statement read.
"Put simply, our nation would provide the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our citizens should a new health crisis arise."
Sovereignty and Global Health
He also said that the American exit from the global health body and its pursuit of one-on-one deals were disrupting structures already established through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This framework is designed to guarantee that when a nation provides its information, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome continued discussions with our American counterparts on how future collaboration might be structured in a way that respects the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but suggested that negotiations must proceed considering much of the nation's HIV programmes were funded by external financing.
"If specific concerns arise, including those relating to information security or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," it commented.
The situation highlights the continuing tensions between accepting vital international aid and safeguarding national sovereignty in an ever more interconnected world.